Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sampat

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The British Journal of Surgery|March 15, 2021
Fetal surgeryK Sampat, P D Losty
The British Journal of Surgery|January 21, 2016
Transitional care and paediatric surgeryK Sampat, P D Losty
Annals of the Royal College of Surgeons of England|June 30, 2017
Perianal rhabdomyomatous mesenchymal hamartomaK Sampat, E Cheesman, S Siminas
The Journal of the Association of Physicians of India|January 31, 2014
Granulocyte macrophage colony stimulating factor therapy for pulmonary alveolar proteinosisRuchira P Shende, Bhavin K Sampat, Pralhad Prabhudesai, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The British Journal of Surgery|March 15, 2021
Fetal surgeryK Sampat, P D Losty
The British Journal of Surgery|January 21, 2016
Transitional care and paediatric surgeryK Sampat, P D Losty
Annals of the Royal College of Surgeons of England|June 30, 2017
Perianal rhabdomyomatous mesenchymal hamartomaK Sampat, E Cheesman, S Siminas
The Journal of the Association of Physicians of India|January 31, 2014
Granulocyte macrophage colony stimulating factor therapy for pulmonary alveolar proteinosisRuchira P Shende, Bhavin K Sampat, Pralhad Prabhudesai, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Pageof 1